Patent · US Active

Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors

US8193190B2 · kind B2 · utility

5Cited by

3References

12Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Marco Baroni · Mantova, IT
Francoise Bono · Paris, FR
Sandrine Delbary-Gossart · Mauzac, FR

Key dates

Filing date	Dec 13, 2010
Grant date	Jun 5, 2012
Priority date	—
Expiry date	Dec 13, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I):in which the variables are as defined herein, to the preparation thereof and to the therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.